Drug Shortage Report for FLUDARABINE PHOSPHATE FOR INJECTION

Last updated on 2018-11-08 History
Report ID 58634
Drug Identification Number 02283859
Brand name FLUDARABINE PHOSPHATE FOR INJECTION
Common or Proper name FLUDARABINE
Company Name TEVA CANADA LIMITED
Active Ingredient(s) FLUDARABINE PHOSPHATE
Strength(s) 25MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2ML
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-08-20
Estimated end date 2018-10-29
Actual end date 2018-10-30
Shortage status Resolved
Updated date 2018-11-08
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2018-11-08 French Compare
v5 2018-11-08 English Compare
v4 2018-10-10 French Compare
v3 2018-10-10 English Compare
v2 2018-08-21 French Compare
v1 2018-08-21 English Compare